| http://www.w3.org/ns/prov#value | - Of clinical significance, nonaminoglycoside small molecules are less toxic than aminoglycosides and are able to pass through the blood brain barrier, which would enable treatment of neurodegenerative forms of XP. Unlike previous studies, this study employed a cell-based system that uses skin cells from XP patients and is probably more likely to be representative of physiological effects in human s
|
